News Conference News AHA 2025 Liberal Transfusion Doesn’t Decrease MACE in Surgery Patients at High Cardiac Risk: TOP Caitlin E. Cox November 10, 2025
News Conference News STS 2024 Multiarterial Grafting in CABG Triumphs Again in Large Database Study Yael L. Maxwell January 29, 2024
News Conference News EACTS 2023 SWEDEHEART Hints at Mortality Benefit With Statins After SAVR Michael O'Riordan October 05, 2023
News Daily News Patient ‘Progressing Well’ After Second Pig-to-Human Heart Transplant Yael L. Maxwell September 26, 2023
News Daily News Surgeons Say ACC/AHA Chronic Coronary Disease Guidelines Whiffed Michael O'Riordan August 03, 2023
News Daily News Worse CABG Outcomes in Women Haven’t Budged in Over a Decade: STS L.A. McKeown March 03, 2023
News Conference News STS 2023 Surgeons Argue: STS Data Again Show ISCHEMIA Isn’t Definitive for CABG Yael L. Maxwell January 30, 2023
News Conference News EACTS 2022 Adjunctive Radial Artery Grafts No Better Than SVGs in Multivessel CABG Michael O'Riordan October 12, 2022
News Conference News EACTS 2022 FFR/iFR No Help in CABG Surgery in SWEDEHEART Registry Michael O'Riordan October 07, 2022
News Industry News Robocath’s Joint Venture, Cathbot, Concludes First Clinical Study in China to Evaluate Robotic PCI Safety and Efficacy July 20, 2022
News Daily News Don’t Rule Out CABG for Elderly Patients With Multiple Comorbidities Michael O'Riordan April 25, 2022
News Conference News HRS 2021 Spinal Cord Stimulation Reduces Post-CABG AF: Pilot Study Michael O'Riordan July 30, 2021
News Daily News OMT Boosts Survival in Revascularized Patients at 10 Years Michael O'Riordan June 29, 2021
News Conference News STS 2021 Surgeons More Likely to Stray From CABG Best Practices in Female Patients Caitlin E. Cox February 03, 2021
News Daily News Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL Michael O'Riordan January 17, 2020
News Daily News Multiarterial CABG ‘Underused’ in Contemporary Practice, Decreases Mortality Yael L. Maxwell October 28, 2019
News Daily News Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES Michael O'Riordan August 26, 2019